Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07570888 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis Subtypes, With the Aim of Providing Clinicians With Assurance That This is an Appropriate Therapeutic Combination.

Study acronym: NERAM-PF
StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
This is a trial designed to evaluate the combination of nerandomilast with mycophenolate across a wide variety of pulmonary fibrosis subtypes, with the aim of providing clinicians with assurance that this is an appropriate therapeutic combination.
Trial Details
NCT Number NCT07570888
Lead Sponsor University of British Columbia
Collaborators: Boehringer Ingelheim
Conditions
(from sponsor)		 Pulmonary Fibrosis, Interstitial Lung Disease (ILD)
Related terms Lung Diseases, Interstitial, Pulmonary Fibrosis
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov